The simultaneous loss of p14 and p16 gives rise to the so-called “melanoma-astrocytoma syndrome”, which is characterized by the presence of melanomas and astrocytomas and, occasionally, of other nervous-system neoplasms, such as peripheral nerve sheath tumors and meningiomas [37]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).